Table 1.
Univariate and multivariate Cox regression analyses of PLOD2 expression for overall survival (OS) in patients with cervical cancer from The Cancer Genome Atlas (TCGA) dataset.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
| Clinical stage (stage III and stage IV vs. stage I and stage II) | 302 | 2.329 (1.432-3.788) | <0.001 | 1.543 (0.762-3.126) | 0.228 |
| BMI (>25 vs. ≤25) | 263 | 0.599 (0.348-1.033) | 0.065 | 0.841 (0.433-1.631) | 0.608 |
| Birth control pill history (yes vs. no) | 160 | 0.674 (0.325-1.398) | 0.289 | ||
| Age (>50 vs. ≤50) | 309 | 1.281 (0.805-2.037) | 0.296 | ||
| Primary therapy outcome (CR vs. PD and SD and PR) | 221 | 0.072 (0.039-0.133) | <0.001 | 0.069 (0.033-0.144) | <0.001 |